unknown by Jonathan Dushoff
BioMed Central
Emerging Themes in Epidemiology
ssOpen AcceCommentary
Assessing influenza-related mortality: Comment on Zucs et al.
Jonathan Dushoff*1,2
Address: 1Princeton U. Dept. of Ecology and Evolutionary Biology, Princeton NJ, 08544, USA, 2National Institutes of Health, Fogarty International 
Center, Bethesda MD, 20892, USA
Email: Jonathan Dushoff* - dushoff@eno.princeton.edu
* Corresponding author    
Influenza is an important source of mortality and morbid-
ity, and an important public health priority. Measuring
the health burden imposed by influenza viruses is an
important, and still controversial, question. Some authors
argue that influenza is directly or indirectly responsible
for the majority of seasonal excess deaths in temperate
countries [1], while others argue that they trigger only a
small minority [2]. Retrospective cohort studies have
shown a surprisingly large protective effect of influenza
vaccination against deaths from any cause [3-5], and one
author has provocatively suggested that increased influ-
enza vaccination of the elderly could halve the total mor-
tality rate [6]. The population-level interpretation of these
cohort studies is not clear, however [7], and studies in the
Netherlands [8] and Britain [9] have found substantially
lower protection. The present contribution [10] is a wel-
come addition to the data base that can be used to address
this important question. But much more remains to be
done to standardize and improve methods, and to recon-
cile the results obtained from different approaches.
The impact of influenza is difficult to measure, because
there is a great deal of influenza-like illness (ILI) in the
world, caused by a large number of viruses, and only a
very small percentage of cases is confirmed virologically
[11]. Deaths triggered by influenza may be attributed to a
number of final causes, including pneumonia, heart dis-
ease and stroke, and may occur weeks after initial infec-
tion [1,12,13].
The work of [10] is based on a long tradition of estimating
influenza deaths by inference from seasonal patterns in
death series. This method was pioneered by Serfling [14],
and further developed by workers including Simonsen
and colleagues [7,15]. While this work is valuable, and
has produced apparently robust results, it is largely dis-
connected from quantitative virologic data about influ-
enza. Thus, attribution of health effects to influenza is
based strongly on assumptions about underlying death
trends.
Recently, Thompson and colleagues have used virologic
surveillance data to estimate influenza mortality [13] and
hospitalizations [16], using a weekly, seasonal regression
model. These models are the first to link quantitative viro-
logic information to measures of influenza burden at the
population level. The estimates produced are consistent
with those of Serfling-like estimates [7,17] and are robust
to the addition of estimates of respiratory syncytial virus
(RSV) prevalence to the regressions. Questions remain
about these estimates, however. The work of Thompson
and colleagues removes a sinusoidal trend (fit at the same
time as influenza prevalence), but does not take into
account issues of autocorrelations; or the possibility of
seasonal confounding between influenza prevalence,
morbidity and mortality, and such factors as day length,
temperature or school terms; or the likelihood that deaths
caused by influenza infection in a given week may not
occur until several weeks later.
Keatinge, Donaldson and colleagues [2,18], also used
simple regression methods that ignored autocorrelations
and seasonal confounding to study the causes of winter
mortality in Europe. Unlike Thompson and colleagues,
they lacked virological data and instead used proxies for
influenza, but included temperature data, and found that
temperature rather than influenza explained most of the
excess deaths in their models.
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Emerging Themes in Epidemiology 2005, 2:7 http://www.ete-online.com/content/2/1/7Approaching a consensus on the health and mortality bur-
den of influenza, and on the cause of winter excess mor-
tality in general, is an important scientific and public-
policy goal. For this to happen, further progess is needed
in several areas.
• Employing virological data. When possible, analyses of
influenza burden should be tied to estimates of labora-
tory-confirmed influenza cases. In some cases, such meas-
ures can be combined with ILI surveillance to improve
estimates. Efforts should be made to increase the amount
of viral surveillance information available in the public
domain, with spatial and temporal break downs.
• More sophisticated statistical analyses. Time series methods
that address issues of seasonal confounding and autocor-
relation are available [19,20], but have been little used in
analyses of seasonal mortality. Helfenstein [21] analyzed
paired pre-whitened mortality series and inferred a "hid-
den relation" underlying heart disease in women and
men. Much more needs to be done to investigate the rela-
tionship between mortality (or morbidity) and co-factors
including weather, air pollution and epidemics of influ-
enza and other viruses, while accounting for seasonal con-
founding and autocorrelations. Methods should evaluate
multiple risk factors and consider the possibility of inter-
actions between them.
• Discuss and define time scales. An important, and usually
unasked, question in comparing results from different
estimation approaches is the time scale on which influ-
enza deaths are being measured. Everybody dies, so what
is being measured as the mortality burden of influenza (or
of weather) is deaths that are hastened by the cause in
question. The question is whether these deaths are being
hastened by weeks, months or years. Regressions that use
a weekly time frame are expected to count deaths hastened
by even a few weeks, while traditional methods of sum-
ming excess deaths over a season of 3 months or longer
will be measuring at a different time scale.
• Quantitative spatial comparisons. As regional surveillance
data, and data from different countries, become more
available, analyses that explicitly incorporate risk factors
and health outcome variables from various localities have
the potential to greatly increase statistical power and shed
light on unravelling the contribution of influenza and
other risk factors to mortality and morbidity.
The contribution of influenza to morbidity and mortality
– and, more broadly, cataloging the causes of daily and
seasonal excess deaths and hospitalizations – remain as
unresolved questions with important scientific and pub-
lic-health implications. There is a pressing need for more
communication between researchers studying different
causes, places and time scales, and for application of
appropriate, powerful statistical methods to these ques-
tions.
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